Cargando…

Management of infusion reactions associated with cetuximab treatment: A case report

Cetuximab is a drug targeting the epidermal growth factor receptor, which is indicated for the treatment of unresectable advanced or recurrent head and neck or colorectal cancer. Cetuximab also enhances the cytotoxic effects of radiation in squamous cell carcinoma. The severity of infusion reactions...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ohshita, Naohiro, Ichimaru, Yuri, Gamoh, Shoko, Tsuji, Kaname, Kishimoto, Naotaka, Tsutsumi, Yasuo M., Momota, Yoshihiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451859/ https://www.ncbi.nlm.nih.gov/pubmed/28588776 http://dx.doi.org/10.3892/mco.2017.1242

Ejemplares similares

Allergic/infusion reactions reported with cetuximab and rituximab
por: Wolf, Ray A, et al.
Publicado: (2015)

Compliance with infection control practices when taking dental x‐rays: Survey of a Japanese dental school
por: Gamoh, Shoko, et al.
Publicado: (2018)

Hyperventilation syndrome in an aged male patient
por: Kishimoto, Naotaka, et al.
Publicado: (2017)

High incidence of cetuximab-related infusion reactions in head and neck patients
por: Palomar Coloma, Virginia, et al.
Publicado: (2018)

Intracranial meningeal melanocytoma diagnosed using an interdisciplinary approach: a case report and review of the literature
por: Gamoh, Shoko, et al.
Publicado: (2018)

Clinical and economic impact of infusion reactions in patients with colorectal cancer treated with cetuximab
por: Foley, K. A., et al.
Publicado: (2010)

The role of computed tomography and magnetic resonance imaging in diagnosing clear cell ameloblastoma: A case report
por: Gamoh, Shoko, et al.
Publicado: (2017)

Incidence of cetuximab-related infusion reaction in head and neck cancer patients: may we predict it?
por: Merlano, Marco C, et al.
Publicado: (2018)

A retrospective analysis of cross-reacting cetuximab IgE antibody and its association with severe infusion reactions
por: Maier, Sabine, et al.
Publicado: (2015)

Successful rechallenge with cetuximab after an infusion related reaction to panitumumab in a patient with locally advanced rectal cancer
por: Yokokawa, Hideyuki, et al.
Publicado: (2020)

The osteoblastic differentiation ability of human dedifferentiated fat cells is higher than that of adipose stem cells from the buccal fat pad
por: Kishimoto, Naotaka, et al.
Publicado: (2013)

Prospective practice survey of management of cetuximab-related skin reactions
por: Lugtenberg, R. T., et al.
Publicado: (2020)

Retrospective analysis of premedication, glucocorticosteroids, and H(1)-antihistamines for preventing infusion reactions associated with cetuximab treatment of patients with head and neck cancer
por: Ikegawa, Kiwako, et al.
Publicado: (2017)

Anaphylactoid hypersensitivity reaction from intra-arterial cetuximab: Clinical considerations and management
por: Bardash, Yonatan, et al.
Publicado: (2019)

Cetuximab in the management of colorectal cancer
por: Lenz, Heinz-Josef
Publicado: (2007)

Protective efficacy of stockpiled vaccine against H5N8 highly pathogenic avian influenza virus isolated from a chicken in Kumamoto prefecture, Japan, in 2014
por: GAMOH, Koichiro, et al.
Publicado: (2015)

Incidence and Management of Olaratumab Infusion-Related Reactions
por: Van Tine, Brian A., et al.
Publicado: (2019)

Severe skin reaction secondary to concomitant radiotherapy plus cetuximab
por: Berger, Bernhard, et al.
Publicado: (2008)

Incidence and associated factors of cetuximab-induced hypersensitivity infusion reactions in 1392 cancer patients treated in four French areas: a possible association with Lyme disease?
por: Dupont, M, et al.
Publicado: (2022)

Cardiac Arrest Induced by an Anaphylactic Reaction Associated With the First Dose of Cetuximab
por: Hane, Atsuya, et al.
Publicado: (2022)

Bananas decrease acetaminophen potency in in vitro assays
por: Uesawa, Yoshihiro, et al.
Publicado: (2018)

Prospective, observational practice survey of applied skin care and management of cetuximab-related skin reactions: PROSKIN study
por: Rothschild, Sacha I., et al.
Publicado: (2019)

Incidence and Management of Infusion Reactions to Infliximab in an Alternate Care Setting
por: Checkley, L. Allyson, et al.
Publicado: (2018)

Brentuximab Vedotin Infusion Reaction Management: A Case Study
por: Comer, Holly, et al.
Publicado: (2017)

Antineoplastics: Lack of efficacy and infusion reaction: case report
Publicado: (2022)

Severe Infusion Reactions to Cetuximab Occur within 1 h in Patients with Metastatic Colorectal Cancer: Results of a Nationwide, Multicenter, Prospective Registry Study of 2126 Patients in Japan
por: Yamaguchi, Kensei, et al.
Publicado: (2014)

Late Reaction to Ustekinumab Infusion
por: Morais, Marina Resener, et al.
Publicado: (2013)

Cetuximab as salvage monotherapy in chemotherapy-refractory metastatic colorectal cancer: A single-center report
por: MEKATA, EIJI, et al.
Publicado: (2013)

Neurokinin-1 receptor antagonists for postoperative nausea and vomiting: a systematic review and meta-analysis
por: Murakami, Chiaki, et al.
Publicado: (2020)

Tele-monitoring and tele-sedation for systemic management during dental treatment
por: Kishimoto, Naotaka, et al.
Publicado: (2020)

Cetuximab in Refractory Skin Cancer Treatment
por: Kalapurakal, Sini J, et al.
Publicado: (2012)

Cetuximab-induced esophageal ulcer: the first report in literature
por: Babacan, Taner, et al.
Publicado: (2014)

Common infusion-related reactions to subcutaneous immunoglobulin therapy: Managing patient expectations
por: Wasserman, Richard L.
Publicado: (2008)

Tomotherapy concomitant with cetuximab, followed by cetuximab as single-agent therapy for unresectable squamous cell carcinoma of the skin: a case report
por: Falivene, Sara, et al.
Publicado: (2014)

Impact of additional selexipag on prostacyclin infusion analogs in patients with pulmonary arterial hypertension
por: Momoi, Mizuki, et al.
Publicado: (2022)

Remdesivir: Infusion site reaction following extravasation of remdesivir: case report
Publicado: (2021)

Hepatic arterial infusion but not systemic application of cetuximab in combination with oxaliplatin significantly reduces growth of CC531 colorectal rat liver metastases
por: Sperling, Jens, et al.
Publicado: (2012)

Efficacy of concurrent chemoradiotherapy with retrograde super selective intra-arterial infusion combined with cetuximab for synchronous multifocal oral squamous cell carcinomas
por: Chen, Xuefei, et al.
Publicado: (2023)

Randomized phase II study of cetuximab versus irinotecan and cetuximab in patients with chemo-refractory KRAS codon G13D metastatic colorectal cancer (G13D-study)
por: Nakamura, Masato, et al.
Publicado: (2016)

Calcifying cystic odontogenic tumor accompanied by a dentigerous cyst: A case report
por: Gamoh, Shoko, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_27jbnm662f1vea5rg0fb9nacr5